FABLYN, created in 2000 (United States), from 1125 sister brands and 17477 competing brands. FABLYN is a brand of Pfizer Inc, listed on the stock exchange of New York. FABLYN is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Pfizer Inc
(FABLYN)
over 5 years*
USD 18.86